Bulgaria to Ban Sale of Non-Tobacco Flavored Products in 2024

Regulations by 2FIRSTS.ai
Dec.15.2023
Bulgaria to Ban Sale of Non-Tobacco Flavored Products in 2024
Bulgaria will ban all heated tobacco products, excluding tobacco flavor, from January 1st, 2024, to comply with EU regulations.

According to recent reports by Bulgarian media outlet Novinite, all heated tobacco products, excluding tobacco-flavored ones, will cease to be sold in Bulgaria starting from January 1, 2024. This regulation was established through the revision of the Tobacco and Tobacco Products Act by legislators without causing any controversy.

 

The recently approved amendment to the tobacco and tobacco products law by the House of Representatives has established this provision without any debate. This move is in response to a directive from the European Commission, non-compliance of which could result in criminal prosecution against Bulgaria. The aim of these amendments is to reduce the appeal of heated tobacco products, particularly by eliminating fragrance options.

 

In addition, each package of heated tobacco products must display warnings, emphasizing the associated risks during use.

 

According to the updated legislation, the Bulgarian Ministry of Economy and Industry will be responsible for banning additives in tobacco products that have significantly increased toxicity, addictiveness, or risks of cancer, mutation, or reproductive toxicity.

 

These legislative amendments await formal announcement in the national gazette published by the government.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales
UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales
According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.
Nov.13 by 2FIRSTS.ai
JUUL Plans to Launch New E-cigarette Juul2 in the U.S., Featuring App-Based Identity Verification and Awaiting Regulatory Approval
JUUL Plans to Launch New E-cigarette Juul2 in the U.S., Featuring App-Based Identity Verification and Awaiting Regulatory Approval
JUUL plans to launch Juul2 with biometric protection system in the US, targeting adult smokers while preventing underage use.
Oct.24 by 2FIRSTS.ai
Multiple E-Cigarette Companies Donate to Support Hong Kong Tai Po Fire Relief (List Updating)
Multiple E-Cigarette Companies Donate to Support Hong Kong Tai Po Fire Relief (List Updating)
Following the fire at Hong Kong’s Tai Po Kwong Fuk Estate, several e-cigarette companies have announced donations for relief and recovery. Current contributions include SMOORE (HKD 5 million), ZINWI Bio (RMB 200,000), Heaven Gifts & GEEKVAPE (HKD 3 million), ALD (RMB 1 million), and OXVA (HKD 500,000). The list is being updated.
Dec.02 by 2FIRSTS.ai
Two Malaysian Men Charged Over Illegal Import of  Vape Items at Singapore Checkpoint
Two Malaysian Men Charged Over Illegal Import of Vape Items at Singapore Checkpoint
Two Malaysian men arrested for illegally importing e-cigarettes at Woodlands Checkpoint, facing charges, court hearing on December 15. (20 words)
Nov.18 by 2FIRSTS.ai
Japan Tobacco and Japanese Artist VERDY Team Up Again for Limited-Edition Ploom AURA Collaboration Set
Japan Tobacco and Japanese Artist VERDY Team Up Again for Limited-Edition Ploom AURA Collaboration Set
Japanese artist VERDY has renewed his collaboration with Japan Tobacco’s heated tobacco brand Ploom to launch a limited-edition “Ploom AURA × Wasted Youth” set in December 2025, which will be sold via a one-day pop-up store in Tokyo’s Harajuku district through a lottery system, with part of the lineup also available in limited quantities on Ploom’s online platform.
Dec.09 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21